Login / Signup
Kathryn Loeffler
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 6
Top Topics
Copy Number
Protein Protein
Respiratory Syndrome Coronavirus
Angiotensin Ii
Top Venues
Nature communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Peter J Halfmann
,
Kathryn Loeffler
,
Augustine Duffy
,
Makoto Kuroda
,
Jie E Yang
,
Elizabeth R Wright
,
Yoshihiro Kawaoka
,
Ravi S Kane
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine.
Nature communications
15 (1) (2024)
Peter J Halfmann
,
Kathryn Loeffler
,
Augustine Duffy
,
Makoto Kuroda
,
Jie E Yang
,
Elizabeth R Wright
,
Yoshihiro Kawaoka
,
Ravi S Kane
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine.
Nature communications
15 (1) (2024)
Peter J Halfmann
,
Kathryn Loeffler
,
Augustine Duffy
,
Makoto Kuroda
,
Jie E Yang
,
Elizabeth R Wright
,
Yoshihiro Kawaoka
,
Ravi S Kane
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine.
Nature communications
15 (1) (2024)
Peter J Halfmann
,
Kathryn Loeffler
,
Augustine Duffy
,
Makoto Kuroda
,
Jie E Yang
,
Elizabeth R Wright
,
Yoshihiro Kawaoka
,
Ravi S Kane
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine.
Nature communications
15 (1) (2024)
Peter J Halfmann
,
Kathryn Loeffler
,
Augustine Duffy
,
Makoto Kuroda
,
Jie E Yang
,
Elizabeth R Wright
,
Yoshihiro Kawaoka
,
Ravi S Kane
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine.
Nature communications
15 (1) (2024)
Peter J Halfmann
,
Kathryn Loeffler
,
Augustine Duffy
,
Makoto Kuroda
,
Jie E Yang
,
Elizabeth R Wright
,
Yoshihiro Kawaoka
,
Ravi S Kane
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine.
Nature communications
15 (1) (2024)